This Fascinating Puzzle of a Question
This is post #2 in a five-part introduction.
When I joined the City four years ago, I found myself wrestling with this fascinating puzzle of a question: why is it that NYC, in spite of a phenomenal set of ingredients, has never reached the level of a Boston or a San Francisco as a center for high-tech innovation in the health and life sciences - in biotech, in medtech, in health tech? And what could be done about it?
In the coming months on this blog, I’d like to write about this fundamental question. I’d like to discuss the process we used to rip it apart and pull it all back together, our approach to data-driven problem-solving, the huge pluses and minuses of this approach. I’d like to look back on the hidden rocks and gems we ended up uncovering and discovering in the community, the unique opportunities for social design, the lists and lists of stakeholders we were able to mobilize. Most importantly, I’d like to draw attention to a key idea that helped us answer this question and make a difference for the City of New York.
Context: Infrastructure Needs
First some context. So I wasn’t the first person to get puzzled with this fundamental question. There had always been a recognition that NYC was preeminent in terms of its academic research and clinical care assets, that for some goshforsaken reason, just wasn’t on the commercial side. In the first few months on the job, I found myself attending one panel after another on the topic. Left and right, over and over again I heard the same old thing, “real estate is too expensive in New York City”, “New York is an expensive place to live,” cost of real estate this, cost of living that. To be sure, these have been persistent barriers for New York and don’t quite make for the most hospitable environment for building new companies. Thing is, I was never someone to value money much and was skeptical of what cheaper space or subsidies could ever accomplish. These were important factors, yes. But I wasn’t convinced it would be enough. Something else was missing.
Now the City had mobilized considerable resources on this question through NYCEDC (New York City Economic Development Corporation). As a public entity, NYCEDC’s mandate had always been to manage the real estate assets for the City of New York. As such it would traditionally deploy real estate as the main lever for economic development: identifying an unmet need in the community (say for a waterfront park or small business district), designating a set of City-owned land, and through a competitive RFP, securing a partner in the private sector to develop the land on the City’s behalf. In the case of life sciences, the notorious unmet need had always been for wet commercial laboratory space. And the answer from EDC was a major research and laboratory complex in Manhattan called East River Science Park (now called the Alexandria Center for Life Sciences). When I joined, this project was well under way.
So yea, that was the backdrop. And in the year that I’d arrived, the EDC was beginning to think beyond these types of large-scale capital-intensive projects, to focus on other levers beyond real estate for economic development. In a variety of sectors, the EDC was starting to deploy more grassroots low-cost initiatives like competitions and incubators, to target the specific needs of startups and entrepreneurs.
At the same time, we were beginning to expand the scope of our work beyond pure biotech, to think about other related disciplines, more capital-efficient shorter-time-horizon opportunities like healthcare IT, bioinformatics, diagnostics.
Context: Portfolio of Initiatives Approach
This expanded “portfolio of initiatives” approach was most certainly a move in the right direction. After all, if we go back to this question of what it takes to build a life sciences and healthcare startup hub in NYC, we are truly dealing with a beast of a puzzle, profoundly complex and unyielding to any single answer. Yes, an obsession with real estate would only take us so far.
So I liked this alternative approach and ran with it. I gave it my all trying to spot unmet needs, figure out what specific things we could do for the community. I read every report I could get my hands on, I crunched numbers left and right, thought about it on the train, in the shower, when I went to bed. I met with anyone and everyone, asked them every question, listened to what they had to say.
Yes, we were on the right track. We were spotting unmet needs. The research was illuminating and the ideas were energizing; and I was excited to think through the ways we could support our local entrepreneurs.
But in spite of all this though, it seemed like we needed to take our thinking yet another step further. If we were really going to change the game for New York City, I was convinced we needed a killer answer to this puzzle of a question. Why after all, why hadn’t these unmet needs ever been addressed before?